Arcadia Biosciences, Inc.
RKDA· Nasdaq
Released Nov 11, 2020, after the close
10-Q filed Nov 13, 2020, 44 days after period end · 0001564590-20-053848
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $314.00K | $392.00K | $370.00K | $589.00K |
| Net Income | -$6.39M | -$14.19M | $4.45M | -$4.53M |
| EPS Diluted |
Arcadia Biosciences, Inc. · CIK 1469443 · Engraved from SEC EDGAR
| -$0.60 |
| -$2.04 |
| $0.93 |
| -$2.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.